Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	Duke Clinical Medicine: 235 submissions (showing 76 to 90)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 |

Percutaneous Treatment of Aortic and Mitral Valves
Dr. Raoul Bonan, MD

Direct Thrombin Inhibitors in ACS and MI -- From ACUITY to HORIZONS
Dr. Gregg Stone, MD

New Therapies for Heart Failure
Dr. Adrian Hernandez, MD

Preoperative Assessment of the Cardiac Patient Undergoing Non-Cardiac Surgery: State of the Art
Dr. Kim Eagle, MD

Is Transfer for Direct PCI Feasible Outside Denmark? The MHI Level 1 MI Program Five Years Later
Dr. Tim Henry, MD

Risk Assessment in Contemporary ACS Practice
Dr. L. Kristin Newby, MD

When and Where Should We Use DES?
Dr. James P. Zidar, MD

COURAGE Trial in Perspective: A Panel Discussion
Dr. Michael Blazing, MD

Implications of Updated ACS Guidelines
Dr. Christopher Granger, MD

Drug Eluting Stents - Where Are We Headed?
Dr. David R. Holmes, Jr., MD

Frontiers in Angiogenesis for the Treatment of Peripheral Vascular Disease
Dr. Brian Annex, MD

Transradial Coronary Stenting: 2007
Dr. Tift Mann, MD

The Status of Percutaneous Valvular Heart Disease - A Classic
Dr. Peter C. Block, MD

Management of Stable Coronary Disease: Implications of the COURAGE Trial
Dr. Cindy Grines, MD

Quality PCI Care
Dr. Eric D. Peterson, MD, MPH